You are here

  • Home
  • Archive
  • Volume 2, Issue 2
  • Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study

Article info

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study

Authors

  • Wei Zhang Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, Vancouver, British Columbia, Canada School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Nick Bansback Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, Vancouver, British Columbia, Canada School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Huiying Sun Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Ronald Pedersen Pfizer Inc., Collegeville, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Sameer Kotak Pfizer Inc., Collegeville, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Aslam H Anis Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, Vancouver, British Columbia, Canada School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Aslam H Anis; aslam.anis{at}ubc.ca
View Full Text

Citation

Zhang W, Bansback N, Sun H, et al
Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study
RMD Open 2016;2:e000222. doi: 10.1136/rmdopen-2015-000222

Publication history

  • Received December 7, 2015
  • Revision received May 17, 2016
  • Accepted June 15, 2016
  • First published July 7, 2016.
Online issue publication 
July 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/